期刊文献+

IFN-γ体外诱导沙眼衣原体持续性感染细胞模型的建立 被引量:6

Establishment of the Cell Model for Persistent Infection of Chlamydia Trachomatis Introduced by IFN-γ in vitro
下载PDF
导出
摘要 目的:建立γ-干扰素(IFN-γ)体外诱导沙眼衣原体持续性感染的细胞模型。方法:衣原体感染Mc Coy细胞,实验组加入0.5 ng/m L IFN-γ诱导沙眼衣原体,对照组无IFN-γ诱导,空白组为正常培养的Mc Coy细胞,培养72 h后通过光学显微镜、荧光显微镜、电子显微镜分别观察诱导后衣原体的细胞形态。实验组72 h解除IFN-γ诱导,继续培养48 h,观察衣原体细胞形态学变化。结果:实验组在0.5 ng/m L IFN-γ作用72 h后,碘液染色发现衣原体包涵体的数量比对照组减少,包涵体变小;荧光抗体染色显示衣原体包涵体质地疏松,染色不均匀;透射电子显微镜可见包涵体变小和网状体体积增大等特征的典型异形包涵体。去除IFN-γ作用后,包涵体内致密的EB颗粒数量增加。对照组培养72 h后碘液染色和荧光染色可见典型包涵体,透射电子显微镜可见典型的网状体和原体,充满整个包涵体。结论:成功建立了IFN-γ体外沙眼衣原体持续性感染的细胞模型,为进一步进行沙眼衣原体持续性感染形成机制的研究奠定了基础。 Objective: To establish a cell model of interforn- γ mediated persistent Chlamydia trachomatis infection in vitro. Methods: Mc Coy cells were prepared in culture plates and Chlamydia trachomatis serovar D were incubated for infection. Infected cells with treated or untreated IFN-γ at 0. 5 ng / mL for 72 hours and were harvested. Light microscope,fluorescence microscope and electron microscope were used for structural analysis. The culture medium was then removed and replaced with RPMI1640 for 48 hours after the removal of IFN-γ. The morphological characteristics of the Chlamydia were observed. Results: For iodine stained assay,the infected cells mediated by IFN-γ contained small numbers of inclusions by light microscope. Inclusions lacked of density and the fluorescent dye in the IFN-γ mediated inclusions were uneven through direct immunofluorescent staining. Typical RB and EB formed in inclusions of untreated cells were observed by electronic microscope. The IFN-γ treated cells did not contain typical forms,but instead the inclusions were characterized by large atypical reticulate body. Conclusion: An in vitro cell culture system for IFN-γ mediated persistent Chlamydia trachomatis infection have been established. The persistent infection cell model was the foundation for the mechanism research of persistent Chlamydia.
出处 《皮肤性病诊疗学杂志》 2015年第1期10-13,17,共5页 Journal of Diagnosis and Therapy on Dermato-venereology
基金 广东省科技计划项目(编号:2013B021800169)
关键词 Γ-干扰素 沙眼衣原体 持续性感染 细胞模型 Interforn-γ Chlamydia trachomatis Persistent infection Cell model
  • 相关文献

参考文献12

  • 1Hammerschlag MR.Treatment of Chlamydia trachomatis Infections[M].Basel:Karger,2013,7:89-96.
  • 2杨斌,王柳苑,薛耀华,黄澍杰,文海泉,辛青松,周芳,艾菁,郑和平.女性不同基因型沙眼衣原体生殖道感染与临床表现相关性的初步研究[J].皮肤性病诊疗学杂志,2014,21(5):375-379. 被引量:4
  • 3Vanover J,Kintner J,Whittimore J,et al.Interaction of herpes simplex virus type 2(HSV-2)glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence[J].Microbiology,2010,156(Pt5):1294-1302.
  • 4王柳苑,郑和平,薛耀华,李影,李源,杨斌.不同基因型沙眼衣原体致小鼠生殖道感染的病理研究[J].皮肤性病诊疗学杂志,2013,20(2):80-84. 被引量:5
  • 5Wyrick PB.Chlamydia trachomatis persistence in vitro-an overview[J].J Infect Dis,2010,201(Suppl 2):S88-S95.
  • 6Ibana JA.Belland RJ,Zea AH,et al.Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells[J].Infect Immun,2011,79(11):4425-4437.
  • 7Rodel J,Grosse C,Yu H,et al.Persistent Chlamydia trachomatis infection of He La cells mediates apoptosis resistance through a Chlamydia protease-like activity factorindependent mechanism and induces high mobility group box 1 release[J].Infect Immun,2012,80(1):195-205.
  • 8薛耀华,郑和平,杨斌,周细玉,吴兴中,黄进梅,曾维英.沙眼衣原体临床分离株的抗菌药物敏感性及基因分型研究[J].中华皮肤科杂志,2010,43(5):309-311. 被引量:4
  • 9Beatty WL,Byrne GI,Morrison RP.Morphological and antigen characterization of interforn gamma-mediated persistent Chlamydia trachomatis infection in vitro[J].Proc Natl Acad Sci USA,1993,90(1):3998-4002.
  • 10Meyer T.Diagnosis and treatment of Chlamydia trachomatis infections[J].Hautarzt,2012,63(1):16-23.

二级参考文献36

  • 1郑和平,江丽芳,薛耀华,方丹云,吴亚安,黄进梅.反向斑点杂交技术检测泌尿生殖道沙眼衣原体及基因分型[J].中华皮肤科杂志,2006,39(5):272-274. 被引量:11
  • 2郑和平,江丽芳,方丹云,李美玲,吴兴中,李燕娃,徐钢,薛耀华,冯占芹,吴亚安,黄进梅.不同人群泌尿生殖道沙眼衣原体感染的分子流行病学研究[J].热带医学杂志,2006,6(8):900-902. 被引量:5
  • 3韩建德,陈木开,廖绮曼,王莉红,凌宏忠,涂裕英.生殖道沙眼衣原体对几种抗菌药物敏感性的研究[J].中华皮肤科杂志,2006,39(10):559-561. 被引量:33
  • 4Roberts TE,Robinson S,Barton P,et al.Screening for Chlamydia trachomatis:a systematic review of the economic evaluations and modelling.Sex Transm Infect,2006,82(3):193-200.
  • 5Magbanua JP,Gob BT,Michel CE,et al.Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests:molecular characterisation and failure of single dose azithromycin.Sex Transm Infect,2007,83(4):339-343.
  • 6Notomi T,lkeda Y,Nagayama A.Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.Chemotherapy,1999,45(4):242-248.
  • 7Donati M,Pollini GM,Sparacino M,et al.Comparative in vitro activity of garenoxacin against Chlamydia spp.J Antimicrob Chemother,2002,50 (3):407-410.
  • 8Cross NA,Kellock DJ,Kinghorn GR,et al.Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method.Antimicrob Agents Chemother,1999,43(9):2311-2313.
  • 9CDC. Sexually Transmitted Disease Surveillance 2009 [ Z]. Centers of Disease Control and Prevention, Atlan- ta, GA: U.S. 2010(9):7-16.
  • 10Roberts TE, Robinson S, Barton P, et al. Screening for Chlamydia trachomatis: a systematic review of the eco- nomic evaluations and modelling[ J ]. Sex Transm Infect, 2006, 82(3) : 193-200.

共引文献9

同被引文献48

  • 1刘佳强,吴移谋.衣原体蛋白酶样活性因子的研究进展[J].国际检验医学杂志,2006,27(12):1120-1122. 被引量:4
  • 2Kapil R, Press CG, Hwang WL, et al. Investigating the epidemiology of repeat Chlamydia trachomatis detection after treatment by using C. trachomatis OmpA genotyping [J]. J Clin Microbiol, 2015,53(2) : 546-549.
  • 3Redgrove KA, McLaughlin EA. The role of the immune response in Chlamydia trachomatis infection of the male genital tract: a double-edged Sword[ J]. Front Immunol, 2014,5: 534.
  • 4Lee YS, Lee KS. Chlamydia and male lower urinary tract diseases[J]. Korean J Urol, 2013. 54(2) : 73-77.
  • 5Dean D, Suehland R J, Stamm WE. Evidence for long- term cervical persistence of Chlamydia trachomatis by ompl genotyping[J]. J Infect Dis, 2000, 182(3) : 909- 916.
  • 6Smith A, Mutioz B, Hsieh YH,et al. OmpA genotypie evidence for persistent ocular Chlamydia trachomatis in- fection in Tanzanian village women [ J ]. Ophthalmic Epi- demiol, 2001,8(2-3) : 127-135.
  • 7Gerard HC, Braniqan PJ, Schumacher HR Jr,et al. Syn- ovial Chlamydia trachomatis in patients with reactive ar- thritis/Reiter's syndrome are viable but show aberrant gene expression[ J]. J Rheumatol, 1998, 25 (4): 734- 742.
  • 8Dill BD, Raulston JE. Examination of an inducible ex- pression system for limiting iron availability during Chlamydia trachomatis infection [ J ]. Microbes Infect, 2007, 9(8) : 947-953.
  • 9Jendro MC, Deutsch T, Kiirber B, et al. Infection of hu- man monocyte-derived macrophages with Chlamydia tra- chomatis induces apoptosis of T cells: a potential mecha- nism for persistent infection[ J]. Infect Immun, 2000, 68 (12) : 6704-6711.
  • 10Vanover J, Kintner J, Whittimore J, et al. Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia tra- chomatis persistence [ J]. Microbiology, 2010, 156 ( Pt 5) : 1294-1302.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部